Medical devices, healthcare technology and the business of care
510(k) clearance · K263150

V10 Diagnostic Ultrasound System; cV10 Diagnostic Ultrasound System; H10 Diagnostic Ultrasound System; XV10 Diagnostic Ultrasound System; XH10 Diagnostic Ultrasound System; V10 ONE Diagnostic Ultrasound System; cV10 ONE Diagnostic Ultrasound System; H10 ONE Diagnostic Ultrasound System; XV10 ONE Diagnostic Ultrasound System; XH10 ONE Diagnostic Ultrasound System; HERA Z10 Diagnostic Ultrasound System

Samsung Medison Co., Ltd. · Decision date Oct 8, 2026

MEDTECHLEDGER EXPLANATIONK263150

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-08 for 510(k) K263150, filed by Samsung Medison Co., Ltd. of Hongcheon-Gun, Korea. The submission covers eleven named diagnostic ultrasound systems: V10, cV10, H10, XV10, XH10, V10 ONE, cV10 ONE, H10 ONE, XV10 ONE, XH10 ONE and HERA Z10. The listed classification is System, Imaging, Pulsed Doppler, Ultrasonic, under regulation 892.1550, with primary product code IYN and subsequent codes ITX, IYO and LLZ; the review panel and medical specialty are Radiology.

SESE means the submission was cleared as substantially equivalent to a predicate device; it is not a PMA approval. The record shows a Traditional 510(k) received 09/08/2026, reviewed by a third party, and not a combination product. No predetermined change control plan was authorized. The record does not identify which components or features changed relative to the predicate, the predicate device itself, or any indications for use, so those details remain unknown from this source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 8, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263150
Regulatory pathway
510(k) premarket notification
Product code
IYN
Decision code
SESE
Decision date
Oct 8, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Imaging, Pulsed Doppler, Ultrasonic.

Product code
IYN
FDA device class
2

FDA decision timeline

  1. K263150 received

    Application receipt date recorded by FDA.

  2. K263150 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code IYN

Product / regulatory recordCompanyPathwayDecision dateSource
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.510(k) clearanceOct 16, 2026FDA
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.510(k) clearanceOct 8, 2026FDA
GE Medical Systems Ultrasound and Primary care Diagnostics, LLC510(k) clearanceOct 2, 2026FDA
Philips Ultrasound, LLC510(k) clearanceSep 25, 2026FDA
Samsung Medison Co., Ltd.510(k) clearanceSep 25, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Samsung Medison Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Hongcheon-Gun

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records